A clinical trial to study the effects of two drugs, Eugenia jambolana and Syzygium caryophyllatum leaf in patients with Acne vulgaris

Comparative phyto-pharmocognostic and clinical evaluation of Jambu(Eugenia jambolana Lam.) And Kshudra Jambu(Syzygium caryophyllatum (L.) Alston) W.S.R to their efficacy in youvana pidaka. - EJSC

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023942

Enrollment

133920

Registered

2020-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Oral administration and external application of mature leaf powder of Kshudra jambu: Oral administration-6gm twice a day with hot water,after food. External application- Kshudra jambu l

Eligibility

Inclusion criteria

Inclusion criteria: Shalmali kantaka pidaka, Sarika pidaka, Ghana pidaka, medogarbha

Exclusion criteria

Exclusion criteria: Any systemic illness that requires treatment which might interfere with present clinical trial. Diabetis mellitus, hypertension,Acne rosaceae, Syncosis barbar, gram negative folliculitis

Design outcomes

Primary

Measure	Time frame
Disease managementTimepoint: Disease management	—

Secondary

Measure	Time frame
Minimum side effects and less reoccurence of signs and symptomsTimepoint: 30 days after the stopage of intervention	—

Countries

India

Contacts

Public ContactDr Suma H R

SDM College of ayurveda and hospital

vaidyasuma@outlook.com9449304574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026